Psyence Biomedical sets Jan. 20 as effective date for reverse stock split

Psyence Biomedical (PBM [https://seekingalpha.com/symbol/PBM]) has announced the effective date of its 1-for-6.25 reverse stock split of the company's issued and outstanding common shares.

The common shares are expected to begin trading on a post-consolidated basis at the opening of the market on January 20, 2026. As of January 14, 2026, Psyence Biomedical (PBM [https://seekingalpha.com/symbol/PBM]) had 6.38M common shares issued and outstanding.

As a result of the consolidation, the company will have 1,022,177 common shares issued and outstanding.

At a special meeting of stockholders held on April 16, 2025, shareholders approved a special resolution authorizing the board of directors, at any time before the next annual meeting of shareholders, to implement a share consolidation at a ratio of up to 1-for-50.

Following this approval, the board initially authorized a 1-for-7.97 consolidation ratio, which was implemented on May 5, 2025. On December 4, 2025, the board approved a second share consolidation at a ratio of 1-for-6.25.

Source: Press Release [https://seekingalpha.com/pr/20365167-psyence-biomed-announces-effective-date-for-1-forminus-6_25-reverse-stock-split]

MORE ON PSYENCE BIOMEDICAL LTD.

* Seeking Alpha’s Quant Rating on Psyence Biomedical Ltd. [https://seekingalpha.com/symbol/PBM/ratings/quant-ratings]
* Financial information for Psyence Biomedical Ltd. [https://seekingalpha.com/symbol/PBM/income-statement]